Drugs / V-SARS
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04380532 | May 2020 → May 2021 | COVID-19 | Immunitor LLC | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | V-SARS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04380532 ↗ |
| Modality | Vaccine | “Therapeutic vaccine formulated as a pill derived from heat-inactivated plasma from COVID-19 patients” NCT04380532 ↗ |
| Route | Oral | “administered orally to volunteers” NCT04380532 ↗ |